Showing results (51-60 of 72) with videos related to
Sort By:
Pageof 8
The Journal of Biological Chemistry|July 15, 2004
Activated polyamine catabolism depletes acetyl-CoA pools and suppresses prostate tumor growth in TRAMP miceKristin Kee, Barbara A Foster, Salim Merali, et al.Cancer Research|October 16, 2003
Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferationKevin W Freeman, Rama D Gangula, Bryan E Welm, et al.Cancers|March 11, 2023
HotSPOT: A Computational Tool to Design Targeted Sequencing Panels to Assess Early PhotocarcinogenesisSydney R Grant, Spencer R Rosario, Andrew D Patentreger, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
A Sequential Triple-Drug Strategy for Selective Targeting of p53-Mutant CancersMohammed M Alruwaili, Yanqi Guo, Justin Zonneville, et al.The Prostate|April 15, 2003
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse modelPaula J Kaplan-Lefko, Tsuey-Ming Chen, Michael M Ittmann, et al.Molecular Cancer Therapeutics|August 17, 2012
In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancerChunqing Guo, Huanfa Yi, Xiaofei Yu, et al.Frontiers in Oncology|February 23, 2023
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancerShruti D Shah, Bryan M Gillard, Michelle M Wrobel, et al.Oncotarget|April 29, 2020
Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancerMarina P Antoch, Michelle Wrobel, Bryan Gillard, et al.Cell Reports. Medicine|February 22, 2024
A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancersMohammed M Alruwaili, Justin Zonneville, Maricris N Naranjo, et al.Journal of the National Cancer Institute|October 10, 2014
The Thoc1 ribonucleoprotein and prostate cancer progressionMeenalakshmi Chinnam, Yanqing Wang, Xiaojing Zhang, et al.Pageof 8